Half of people on weight loss drugs quit within one year, Danish study finds – more likely to stop taking the drugs if they were younger, lived in poorer areas, or were men
24
votes
-
-
US health insurance premiums poised to spike over drug costs, tariff threats
15 votes -
Novo Nordisk's ad campaign, which aimed to speak ‘without filters’ by declaring obesity a disease, has faced strong criticism on social media and from some scientific societies
21 votes -
Eleven spouses on what it’s like to live with someone on Ozempic
36 votes -
New anti-obesity drugs will outperform Ozempic
19 votes -
The American physicians are healing themselves with Ozempic
31 votes -
The growing scientific case for using Ozempic and other GLP-1s to treat opioid, alcohol, and nicotine addiction
39 votes -
Novo Nordisk is to invest more than $4bn in US manufacturing as it battles to keep up with booming demand for its obesity and diabetes drugs Wegovy and Ozempic
9 votes -
Ozempic cuts alcohol cravings. Liquor companies aren’t ready.
30 votes -
In the Gulf, a growing scramble for Ozempic and other weight-loss drugs
8 votes -
Some patients who took weight-loss drugs face disturbing side effects
33 votes -
Most patients using weight-loss drugs like Wegovy stop within a year, data show
10 votes -
Goodbye, Ozempic
33 votes -
US medical insurers clamping down on doctors who prescribe Ozempic for weight loss
22 votes